Alan L Chin, MD
Gastroenterology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 4
Offices
4 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chin’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A62137 · Current
Licensed to practise in California · since 1997 · expires 2028-07-31 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Year by year
| 2016 | 18 | 32 | 67 | 1.36 | $32,926 | $5,964 |
| 2014 | 13 | 20 | 73 | 2.75 | $15,800 | $3,012 |
| 2013 | 12 | 18 | 66 | 2.83 | $11,303 | $2,219 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Drugs they prescribed that Part D paid
$73,081
Pharmacies billed $73,081 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 367) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
327 generic and 40 brand-name prescriptions · $73,081 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mesalamine | 24 | $21,237 | $885 |
| Gavilyte-C | 136 | $3,055 | $22 |
| Budesonide Dr | 22 | $1,620 | $74 |
| Mercaptopurine | 16 | $1,087 | $68 |
| Sucralfate | 16 | $800 | $50 |
See all 9 drugs
| Mesalamine | 24 | $21,237 | $885 |
| Gavilyte-C | 136 | $3,055 | $22 |
| Budesonide Dr | 22 | $1,620 | $74 |
| Mercaptopurine | 16 | $1,087 | $68 |
| Sucralfate | 16 | $800 | $50 |
| Cholestyramine | 12 | $464 | $39 |
| Entecavir | 14 | $417 | $30 |
| Famotidine | 31 | $388 | $13 |
| Omeprazole | 26 | $310 | $12 |
Year by year
| 2024 | 367 | 202 | 0% (0) | 11% | $73,081 |
| 2023 | 422 | 256 | 0% (0) | 15% | $57,023 |
| 2022 | 391 | 224 | 0% (0) | 20% | $28,625 |
| 2021 | 380 | 198 | None | 16% | $34,938 |
| 2020 | 321 | 132 | 0% (0) | 20% | $79,927 |
| 2019 | 446 | 246 | None | 17% | $139,352 |
| 2018 | 428 | 264 | 0% (0) | 38% | $189,093 |
| 2017 | 433 | 229 | 0% (0) | 17% | $156,583 |
| 2016 | 431 | 255 | 0% (0) | 21% | $196,170 |
| 2015 | 434 | 255 | 0% (0) | None | $135,477 |
| 2014 | 420 | 221 | 0% (0) | 27% | $99,636 |
| 2013 | 292 | 167 | 0% (0) | 16% | $57,101 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Lialda | 15 | $10,039 | $669 |
| Gavilyte-C | 176 | $3,656 | $21 |
| Peg-3350 and Electrolytes | 43 | $1,091 | $25 |
| Mercaptopurine | 14 | $1,024 | $73 |
| Cholestyramine | 24 | $908 | $38 |
| Famotidine | 28 | $319 | $11 |
| Omeprazole | 20 | $168 | $8 |
| Pantoprazole | 11 | $126 | $11 |
2022: 6 drugs
| Lialda | 16 | $9,712 | $607 |
| Gavilyte-C | 126 | $2,140 | $17 |
| Peg-3350 and Electrolytes | 46 | $1,006 | $22 |
| Lactulose | 16 | $855 | $53 |
| Famotidine | 31 | $361 | $12 |
| Omeprazole | 27 | $207 | $8 |
2021: 9 drugs
| Lialda | 17 | $11,789 | $693 |
| Budesonide Ec | 14 | $2,027 | $145 |
| Peg-3350 and Electrolytes | 95 | $1,927 | $20 |
| Cholestyramine | 17 | $999 | $59 |
| Gavilyte-C | 58 | $873 | $15 |
| Sucralfate | 13 | $613 | $47 |
| Lactulose | 22 | $504 | $23 |
| Famotidine | 39 | $420 | $11 |
| Omeprazole | 19 | $278 | $15 |
2020: 9 drugs
| Xifaxan | 12 | $29,516 | $2,460 |
| Lialda | 15 | $10,642 | $709 |
| Gavilyte-C | 59 | $1,185 | $20 |
| Cholestyramine | 16 | $1,070 | $67 |
| Omeprazole | 29 | $520 | $18 |
| Pantoprazole | 27 | $434 | $16 |
| Lactulose | 15 | $420 | $28 |
| Famotidine | 38 | $326 | $9 |
| Peg-3350 and Electrolytes | 11 | $238 | $22 |
2019: 10 drugs
| Xifaxan | 15 | $32,891 | $2,193 |
| Lialda | 16 | $17,293 | $1,081 |
| Gavilyte-C | 173 | $6,124 | $35 |
| Mercaptopurine | 17 | $2,370 | $139 |
| Entecavir | 11 | $1,845 | $168 |
| Lactulose | 19 | $592 | $31 |
| Omeprazole | 28 | $512 | $18 |
| Pantoprazole | 21 | $507 | $24 |
| Famotidine | 29 | $336 | $12 |
| Gavilyte-G | 11 | $266 | $24 |
2018: 11 drugs
| Humira | 13 | $102,286 | $7,868 |
| Xifaxan | 12 | $25,452 | $2,121 |
| Lialda | 13 | $22,199 | $1,708 |
| Gavilyte-C | 101 | $3,656 | $36 |
| Peg 3350-Electrolyte | 94 | $3,403 | $36 |
| Mercaptopurine | 13 | $2,767 | $213 |
| Entecavir | 11 | $1,817 | $165 |
| Pantoprazole | 12 | $565 | $47 |
| Omeprazole | 21 | $505 | $24 |
| Lactulose | 17 | $463 | $27 |
| Famotidine | 22 | $356 | $16 |
2017: 9 drugs
| Humira | 11 | $40,609 | $3,692 |
| Lialda | 21 | $37,524 | $1,787 |
| Entecavir | 17 | $12,541 | $738 |
| Mercaptopurine | 15 | $4,165 | $278 |
| Gavilyte-C | 173 | $2,961 | $17 |
| Pantoprazole | 16 | $693 | $43 |
| Omeprazole | 24 | $587 | $24 |
| Lactulose | 24 | $575 | $24 |
| Famotidine | 23 | $460 | $20 |
2016: 9 drugs
| Entecavir | 15 | $26,809 | $1,787 |
| Xifaxan | 13 | $24,225 | $1,863 |
| Lialda | 16 | $22,710 | $1,419 |
| Balsalazide Disodium | 17 | $18,388 | $1,082 |
| Mercaptopurine | 17 | $3,833 | $225 |
| Gavilyte-C | 186 | $3,162 | $17 |
| Omeprazole | 21 | $669 | $32 |
| Pantoprazole | 12 | $482 | $40 |
| Famotidine | 19 | $461 | $24 |
2015: 7 drugs
| Lialda | 12 | $23,575 | $1,965 |
| Carafate | 11 | $5,693 | $518 |
| Mercaptopurine | 16 | $3,833 | $240 |
| Gavilyte-C | 199 | $3,383 | $17 |
| Omeprazole | 24 | $996 | $41 |
| Famotidine | 26 | $558 | $21 |
| Pantoprazole | 13 | $530 | $41 |
2014: 8 drugs
| Lialda | 12 | $22,296 | $1,858 |
| Carafate | 12 | $5,295 | $441 |
| Mercaptopurine | 18 | $2,821 | $157 |
| Gavilyte-C | 134 | $2,314 | $17 |
| Omeprazole | 40 | $1,591 | $40 |
| Pantoprazole | 16 | $632 | $39 |
| Peg 3350-Electrolyte | 36 | $624 | $17 |
| Famotidine | 15 | $257 | $17 |
2013: 5 drugs
| Nexium | 13 | $9,322 | $717 |
| Gavilyte-C | 114 | $1,938 | $17 |
| Lactulose | 16 | $1,312 | $82 |
| Omeprazole | 31 | $1,184 | $38 |
| Pantoprazole | 13 | $496 | $38 |
Money from drug and device companies
$11 in 2021
A payment is not proof that care is biased.
| Celgene | Zeposia | $11 | 1 payment
|
See the published payment
| Celgene | Meals · 2021-08-26 | Zeposia | $11 |
Professional record
- NPI
- 1750467262
- Licence
- CA A62137California A62137: Current · expires 2028-07-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A621370
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 1800 Harrison St Fl 7, Oakland, CA, 94612
- NPI first listed
- 2006-10-27
- NPI last updated
- 2021-12-13
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.